These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 17283283)
1. Effects of gamma-aminobutyric acid-modulating drugs on working memory and brain function in patients with schizophrenia. Menzies L; Ooi C; Kamath S; Suckling J; McKenna P; Fletcher P; Bullmore E; Stephenson C Arch Gen Psychiatry; 2007 Feb; 64(2):156-67. PubMed ID: 17283283 [TBL] [Abstract][Full Text] [Related]
3. In vivo measurement of GABA transmission in healthy subjects and schizophrenia patients. Frankle WG; Cho RY; Prasad KM; Mason NS; Paris J; Himes ML; Walker C; Lewis DA; Narendran R Am J Psychiatry; 2015 Nov; 172(11):1148-59. PubMed ID: 26133962 [TBL] [Abstract][Full Text] [Related]
4. Functional magnetic resonance imaging investigation of the amphetamine sensitization model of schizophrenia in healthy male volunteers. O'Daly OG; Joyce D; Stephan KE; Murray RM; Shergill SS Arch Gen Psychiatry; 2011 Jun; 68(6):545-54. PubMed ID: 21300940 [TBL] [Abstract][Full Text] [Related]
5. An investigation of the effects of benzodiazepine receptor ligands and of scopolamine on conceptual priming. Bishop KI; Curran HV Psychopharmacology (Berl); 1998 Dec; 140(3):345-53. PubMed ID: 9877014 [TBL] [Abstract][Full Text] [Related]
6. The neural basis of relational memory deficits in schizophrenia. Ongür D; Cullen TJ; Wolf DH; Rohan M; Barreira P; Zalesak M; Heckers S Arch Gen Psychiatry; 2006 Apr; 63(4):356-65. PubMed ID: 16585464 [TBL] [Abstract][Full Text] [Related]
7. Alterations in cortical interneurons and cognitive function in schizophrenia. Dienel SJ; Lewis DA Neurobiol Dis; 2019 Nov; 131():104208. PubMed ID: 29936230 [TBL] [Abstract][Full Text] [Related]
8. Cortical dysfunction in schizophrenia during auditory word and tone working memory demonstrated by functional magnetic resonance imaging. Stevens AA; Goldman-Rakic PS; Gore JC; Fulbright RK; Wexler BE Arch Gen Psychiatry; 1998 Dec; 55(12):1097-103. PubMed ID: 9862553 [TBL] [Abstract][Full Text] [Related]
9. Auditory mismatch impairments are characterized by core neural dysfunctions in schizophrenia. Gaebler AJ; Mathiak K; Koten JW; König AA; Koush Y; Weyer D; Depner C; Matentzoglu S; Edgar JC; Willmes K; Zvyagintsev M Brain; 2015 May; 138(Pt 5):1410-23. PubMed ID: 25743635 [TBL] [Abstract][Full Text] [Related]
10. Subunit-selective modulation of GABA type A receptor neurotransmission and cognition in schizophrenia. Lewis DA; Cho RY; Carter CS; Eklund K; Forster S; Kelly MA; Montrose D Am J Psychiatry; 2008 Dec; 165(12):1585-93. PubMed ID: 18923067 [TBL] [Abstract][Full Text] [Related]
11. Enhancement of GABA-related signalling is associated with increase of functional connectivity in human cortex. Fingelkurts AA; Fingelkurts AA; Kivisaari R; Pekkonen E; Ilmoniemi RJ; Kähkönen S Hum Brain Mapp; 2004 May; 22(1):27-39. PubMed ID: 15083524 [TBL] [Abstract][Full Text] [Related]
13. Abnormal GABAergic function and negative affect in schizophrenia. Taylor SF; Demeter E; Phan KL; Tso IF; Welsh RC Neuropsychopharmacology; 2014 Mar; 39(4):1000-8. PubMed ID: 24154667 [TBL] [Abstract][Full Text] [Related]
14. GABAergic modulation of visual gamma and alpha oscillations and its consequences for working memory performance. Lozano-Soldevilla D; ter Huurne N; Cools R; Jensen O Curr Biol; 2014 Dec; 24(24):2878-87. PubMed ID: 25454585 [TBL] [Abstract][Full Text] [Related]
15. GABA neuron alterations, cortical circuit dysfunction and cognitive deficits in schizophrenia. Gonzalez-Burgos G; Fish KN; Lewis DA Neural Plast; 2011; 2011():723184. PubMed ID: 21904685 [TBL] [Abstract][Full Text] [Related]
16. Effects of treatment with the atypical neuroleptic quetiapine on working memory function: a functional MRI follow-up investigation. Meisenzahl EM; Scheuerecker J; Zipse M; Ufer S; Wiesmann M; Frodl T; Koutsouleris N; Zetzsche T; Schmitt G; Riedel M; Spellmann I; Dehning S; Linn J; Brückmann H; Möller HJ Eur Arch Psychiatry Clin Neurosci; 2006 Dec; 256(8):522-31. PubMed ID: 17151834 [TBL] [Abstract][Full Text] [Related]
17. Selective deficits in prefrontal cortex function in medication-naive patients with schizophrenia. Barch DM; Carter CS; Braver TS; Sabb FW; MacDonald A; Noll DC; Cohen JD Arch Gen Psychiatry; 2001 Mar; 58(3):280-8. PubMed ID: 11231835 [TBL] [Abstract][Full Text] [Related]
18. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Ho BC; Milev P; O'Leary DS; Librant A; Andreasen NC; Wassink TH Arch Gen Psychiatry; 2006 Jul; 63(7):731-40. PubMed ID: 16818862 [TBL] [Abstract][Full Text] [Related]
19. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers. de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696 [TBL] [Abstract][Full Text] [Related]
20. Psychopharmacological analysis of implicit and explicit memory: a study with lorazepam and the benzodiazepine antagonist flumazenil. Bishop KI; Curran HV Psychopharmacology (Berl); 1995 Sep; 121(2):267-78. PubMed ID: 8545533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]